UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061480
Receipt number R000070248
Scientific Title Single-arm intervention study on the effect of interferential current electrical stimulation of the neck on swallowing function in acute stroke patients
Date of disclosure of the study information 2026/05/08
Last modified on 2026/05/07 18:28:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of interferential current electrical stimulation of the neck on swallowing function in acute stroke patients

Acronym

IFC-Stroke Study

Scientific Title

Single-arm intervention study on the effect of interferential current electrical stimulation of the neck on swallowing function in acute stroke patients

Scientific Title:Acronym

IFC-Stroke Study

Region

Japan


Condition

Condition

Stroke

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore the feasibility of continuous application, changes in oral intake status, and changes in the citric acid cough test, which is thought to reflect silent aspiration, following transcutaneous interferential current electrical stimulation of the neck in the acute phase of stroke.

Basic objectives2

Others

Basic objectives -Others

Neurological findings, such as NIHSS, FIM, and FMA, will be collected to compare pre- and post-intervention data.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The proportion of patients who could continue transcutaneous interferential current electrical stimulation of the neck as scheduled until 14 days after the start of intervention (or at the time of discharge) (completion rate)

Key secondary outcomes

Functional Oral Intake Scale (FOIS), 1% citric acid cough test before and after intervention, incidence of hospital-acquired pneumonia, modified Rankin Scale (mRS), National Institutes of Health Stroke Scale (NIHSS), Functional Independence Measure (FIM), and Fugl-Meyer Assessment (FMA).


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Transcutaneous interferential current electrical stimulation of the neck

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients with acute stroke aged 18 years or older and within 7 days of onset.

2.Patients with a Functional Oral Intake Scale (FOIS) score of 6 or less at the time of obtaining consent.

3.Patients with a Japan Coma Scale (JCS) score of less than 30.

4.Individuals who provide written informed consent for participation in this study, either personally or through a legally authorized representative.

Key exclusion criteria

1.Patients with a history of surgery for neck cancer.

2.Patients with implanted medical devices (e.g., cardiac pacemakers, cochlear implants).

3.Patients with a pulse rate of less than 40 beats per minute.

4.Pregnant or lactating women.

5.Patients judged as inappropriate for participation by the principal investigator.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Hirofumi
Middle name
Last name Maruyama

Organization

Graduate School of Biomedical and Health Sciences, Hiroshima University

Division name

Department of Clinical Neuroscience and Therapeutics

Zip code

734-8551

Address

1-2-3 Kasumi, Minami ward, Hiroshima

TEL

+81-82-257-5201

Email

tomonezu@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Tomohisa
Middle name
Last name Nezu

Organization

Graduate School of Biomedical and Health Sciences, Hiroshima University

Division name

Department of Clinical Neuroscience and Therapeutics

Zip code

734-8551

Address

1-2-3 Kasumi, Minami ward, Hiroshima

TEL

+81-82-257-5201

Homepage URL


Email

tomonezu@hiroshima-u.ac.jp


Sponsor or person

Institute

Graduate School of Biomedical and Health Sciences, Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research (KAKENHI)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3 Minami-Ku, Hiroshima

Tel

082-257-1947

Email

iryo-sinsa@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 04 Month 23 Day

Date of IRB


Anticipated trial start date

2026 Year 07 Month 01 Day

Last follow-up date

2029 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 07 Day

Last modified on

2026 Year 05 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070248